Allan J Pantuck Selected Research

Monoclonal Antibodies

1/2018	Durvalumab: an investigational anti-PD-L1 monoclonal antibody for the treatment of urothelial carcinoma.
7/2017	Adjuvant Weekly Girentuximab Following Nephrectomy for High-Risk Renal Cell Carcinoma: The ARISER Randomized Clinical Trial.
6/2010	Absent CD44v6 expression is an independent predictor of poor urothelial bladder cancer outcome.
3/2005	G250: a carbonic anhydrase IX monoclonal antibody.
2/2003	Monoclonal antibody (MAB) in patients with advanced cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Allan J Pantuck Research Topics

Disease

84	Neoplasms (Cancer) 01/2023 - 01/2002
77	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 02/2002
27	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 05/2002
16	Kidney Neoplasms (Kidney Cancer) 02/2016 - 02/2003
10	Neoplasm Metastasis (Metastasis) 02/2010 - 09/2002
9	Carcinoma (Carcinomatosis) 01/2023 - 02/2003
7	Thrombosis (Thrombus) 01/2019 - 09/2002
7	Hypoxia (Hypoxemia) 01/2015 - 08/2003
5	Urinary Bladder Neoplasms (Bladder Cancer) 01/2017 - 01/2002
3	Lymphatic Metastasis 09/2015 - 08/2003
2	Disease Progression 01/2022 - 07/2006
2	Margins of Excision 01/2020 - 03/2010
2	Melanoma (Melanoma, Malignant) 05/2019 - 03/2005
2	Esophageal Neoplasms (Esophageal Cancer) 01/2017 - 03/2005
2	Testicular Neoplasms (Testicular Cancer) 04/2011 - 07/2002
2	Lymphadenopathy 02/2008 - 06/2003
2	Hypertension (High Blood Pressure) 01/2007 - 12/2003
1	Adenocarcinoma 01/2022
1	Angiomyolipoma 10/2017
1	Carcinoma in Situ 01/2017
1	Skin Neoplasms (Skin Cancer) 01/2017
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 02/2013

Drug/Important Bio-Agent (IBA)

16	Carbonic Anhydrase IXIBA 11/2020 - 02/2003
10	Proteins (Proteins, Gene)FDA Link 01/2017 - 04/2004
9	Sunitinib (Sutent)FDA Link 02/2021 - 01/2007
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2016 - 08/2003
7	Prostate-Specific Antigen (Semenogelase)IBA 01/2022 - 07/2002
7	AntigensIBA 05/2019 - 08/2003
7	Biomarkers (Surrogate Marker)IBA 01/2018 - 03/2005
7	Interleukin-2 (IL2)IBA 02/2015 - 12/2003
5	Hormones (Hormone)IBA 01/2018 - 04/2003
5	Monoclonal AntibodiesIBA 01/2018 - 02/2003
5	Peptides (Polypeptides)IBA 01/2017 - 05/2004
4	EpitopesIBA 01/2017 - 05/2004
4	TOR Serine-Threonine KinasesIBA 01/2016 - 10/2006
3	VaccinesIBA 11/2020 - 09/2003
3	Tumor Biomarkers (Tumor Markers)IBA 01/2017 - 01/2002
3	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 01/2017 - 03/2005
3	ellagitanninIBA 02/2010 - 09/2007
3	Epithelial Cell Adhesion MoleculeIBA 03/2009 - 04/2004
3	AndrogensIBA 06/2003 - 09/2002
2	enzalutamideIBA 10/2021 - 10/2020
2	Androgen Receptors (Androgen Receptor)IBA 10/2021 - 10/2020
2	B7-H1 AntigenIBA 05/2019 - 02/2015
2	Capsules (Microcapsules)IBA 12/2018 - 08/2003
2	abirateroneIBA 01/2018 - 03/2011
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2018 - 10/2006
2	AutoantibodiesIBA 01/2017 - 04/2011
2	NF-kappa B (NF-kB)IBA 01/2015 - 01/2010
2	Recombinant ProteinsIBA 04/2011 - 03/2005
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2011 - 03/2009
2	DNA (Deoxyribonucleic Acid)IBA 08/2009 - 07/2008
2	Vascular Endothelial Growth Factor CIBA 03/2009 - 08/2003
2	VimentinIBA 03/2009 - 08/2003
2	CytokinesIBA 11/2008 - 01/2007
2	Chemokine ReceptorsIBA 01/2008 - 05/2007
2	ChemokinesIBA 01/2008 - 05/2007
2	ParaffinIBA 12/2007 - 08/2006
2	Carbonic Anhydrases (Carbonic Anhydrase)IBA 03/2005 - 08/2003
2	Hemoglobins (Hemoglobin)IBA 05/2004 - 09/2002
2	Thymidine KinaseIBA 09/2002 - 05/2002
1	PlatinumIBA 01/2023
1	Genetic Markers (Genetic Marker)IBA 01/2022
1	GSK2636771IBA 10/2021
1	durvalumabIBA 01/2018
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 10/2017
1	LipidsIBA 10/2017
1	G250 monoclonal antibodyIBA 07/2017
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 07/2017
1	Imiquimod (Aldara)FDA LinkGeneric 01/2017
1	Toll-Like Receptor AgonistsIBA 01/2017
1	TensinsIBA 02/2016
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 02/2016
1	Vascular Endothelial Growth FactorsIBA 01/2016
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2016
1	aldesleukin (Proleukin)FDA Link 02/2015
1	JNK Mitogen-Activated Protein KinasesIBA 01/2015
1	A 19IBA 01/2014
1	Phosphotransferases (Kinase)IBA 10/2013
1	3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-oneIBA 10/2013
1	InterleukinsIBA 05/2013

Therapy/Procedure

54	Nephrectomy 01/2022 - 07/2002
39	Therapeutics 01/2022 - 01/2002
20	Immunotherapy 01/2023 - 09/2002
5	Prostatectomy (Retropubic Prostatectomy) 01/2020 - 04/2003
5	Cryosurgery 06/2014 - 01/2002
4	Thrombectomy 03/2011 - 03/2003
3	Drug Therapy (Chemotherapy) 01/2023 - 07/2002
3	Lymph Node Excision (Lymph Node Dissection) 01/2018 - 09/2002
3	Radiofrequency Ablation 11/2014 - 02/2002
2	Castration 10/2021 - 10/2020
2	Cystectomy 11/2018 - 03/2018
2	Neoadjuvant Therapy 11/2018 - 09/2008
2	Microspheres (Microsphere) 01/2017 - 04/2011
2	Length of Stay 07/2007 - 09/2002
2	Operative Time 07/2007 - 09/2002
2	Cytoreduction Surgical Procedures 03/2003 - 09/2002
1	Nephroureterectomy 06/2019
1	Urinary Diversion (Ileal Conduit) 03/2018
1	Adrenalectomy 02/2016